Reading Our Genome is Tough, But Epigenetics is Giving Us Valuable Clues
By Marcus Woo,
Wired
| 02. 19. 2015
Untitled Document
When scientists sequenced the human genome a decade ago, they hoped to unlock the code of life, the sequence of molecules lined up in every cell that, summed together, made a person a person—and possibly reveal new ways to understand and treat diseases. But the results turned out to be opaque. Biologist Eric Lander, who helped lead the effort, famously summed up the results in seven words: “Genome: Bought the book; hard to read.”
So the research community went looking for CliffsNotes. A decade ago scientists started looking into the “epigenome,” chemical modifications to DNA that tell cells which genes to turn on or turn off. This week that project got a huge data dump—24 journal articles laying out what the genomicists know so far about 111 different cell types, the inner lives of brains, hearts, blood, and skin. “It is giving us a view of the living, breathing genome in motion, as opposed to a static picture of DNA,” says Manolis Kellis, a computational biologist at MIT who worked on two of the new papers.
Just about every...
Related Articles
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Staff, GMWatch | 03.28.2026
Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression or molecular composition in genetically modified (GM) plants differs from conventionally bred plants. As this is an interesting and important...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...